Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Bowel Cancer UK has announced that the charity will be part of the lead committee on bowel cancer in the Genomics England genome sequencing project.
The Genomics England Clinical Interpretation Partnership domain for bowel cancer will be led by Professor Ian Tomlinson from the Wellcome Trust Centre for Human Genetics in Oxford.
Bowel Cancer UK’s CEO Deborah Alsina is on the Steering Group, and co-lead for Training and Education.
Genomics England run the 100,000 Genomes Project, a Department of Health-led project to sequence 100,000 whole genomes from NHS patients by 2017.
The Clinical Interpretation Partnership for bowel cancer will analyse this data to look at how to use this whole genomes data to improve diagnosis and treatment of bowel cancer.
The Steering Group also includes three of Bowel Cancer UK’s Medical Advisory Board: Dr Tim Iveson, Professor Dion Morton and Professor Richard Wilson.
The Genomics England Clinical Interpretation Partnership is likely to last for several years. More information can be found at http://www.genomicsengland.co.uk/about-gecip/.
Source: Bowel Cancer UK
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.